Skip to Main Content

Paper Details

IFI16-dependent STING signaling is a crucial regulator of anti-HER2 immune response in HER2+ breast cancer.
Proc Natl Acad Sci U S A
19
2022
BC, CXCL10/11, EZH2, HDAC, HER2, HER2 BC, HER2 monoclonal antibody, HER2+ breast cancer, IFI16, IRG, STING, T cell, breast cancer, histone, histone deacetylase, immune-, immune-regulated genes, interferon-?, mouse, trastuzumab, tumor
Author NameAffiliation
Dave S B HoonSaint John's Cancer Institute
Dave S B HoonSaint John's Cancer Institute
Qiang YuGenome Institute of Singapore
Qiang YuYong Loo Lin School of Medicine, National University of Singapore
Qiang YuDuke-National University of Singapore Medical School
  • 1 - 5

Datasets

Release 1.2